Vimarsana
Biggest News Aggregation in the World

Pfizer Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Global Today - Breaking & Trending Today

The rise and fall of the Benzo Bros' fake Xanax empire - Vimarsana News

The rise and fall of the Benzo Bros' fake Xanax empire

When an unlikely crew of British gym heads started pumping out counterfeit Xanax online, they thought they had a perfect money-making scheme. Then the private investigations team of the drug giant Pfizer got involved, and it all started to crumble.

(CIIE) Economic Watch: Zoom in on 6th CIIE from six perspectives - Vimarsana News

(CIIE) Economic Watch: Zoom in on 6th CIIE from six perspectives

The sixth China International Import Expo (CIIE), which closed on Friday, saw tentative deals reach a new high, injecting confidence into the sluggish.....

Mallinckrodt Announces Appointment of Susan Silbermann to its Board of Directors - Vimarsana News

Mallinckrodt Announces Appointment of Susan Silbermann to its Board of Directors

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has...

Lyme vaccine trial enrolling participants for phase three - Vimarsana News

Lyme vaccine trial enrolling participants for phase three

A promising clinical study run by Pfizer and Valneva has trial sites across the tri-state area. But the vaccine doesn’t protect against all tick-borne diseases.

Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID (nirmatrelvir tablets; ritonavir tablets) - Vimarsana News

Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID (nirmatrelvir tablets; ritonavir tablets)

14.07.2022 - REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) - Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that the Company has entered into an agreement with Pfizer for the ...